Similarly, the deubiquitinating enzyme OTU deubiquitinase, ubiquitin aldehyde binding 2 (OTUB2) is a glycolytic stimulator which indicates poor survival outcome in NSCLC patients. Here, OTUB2 is linked to non-small cell lung carcinoma.